Abstract: The systems, methods, devices, and non-transitory media of the various embodiments provide query independent data identification. In various embodiments, query independent data identification may be used to facilitate data reuse. Query independent data identification may be accomplished using an algebraic expression hash (AEH) function to identify data in a graph or table for reuse based on its origin and what has been done to the data. Use of an AEH function may support a top down approach for identification of data reuse and may also facilitate faster searches using an AEH value. For example, a hash-based search of a universe of data sets may facilitate a top down approach to locate the maximal reuse first (as opposed to the last) and may be less sensitive to the size of the universe.

Abstract: Systems, methods, devices, and non-transitory media of the various embodiments enable the query execution graph for insertions, deletions, and streaming queries to be manipulated to maximize a portion of the query execution that is independent of data changes.

Abstract: Modular or temporary healthcare building units are provided that interconnect with a patient's home. In one embodiment, one of the modular or temporary units includes a fully-equipped ADA-compliant bathroom. In another embodiment, the modular or temporary unit is referred to as a flex unit and typically accommodates a hospital bed and other associated support structures and features for housing and accommodating a patient that is in a stage of recovery or rehabilitation or, in some cases, the flex unit is used for end-of-life care.

Abstract: Methods for diagnosing and characterizing lymphoma, as well as evaluating the disease-free interval following treatment, utilizing patient antibodies bound to peptide microarrays in comparison to an immunosignature characteristic of a lymphoma state or a non-lymphoma state. Characterization includes subtyping of lymphoma utilizing an immunosignature characteristic of a B-cell or T-cell lymphoma.

Abstract: The invention provides methods for identifying cell binding and/or lytic polypeptides that permit production of specific polypeptide therapeutics in a high throughput manner.

Abstract: Methods for treating breast cancer, specifically cancers resistant to treatment With one or more known breast cancer treatment drugs, and related patient selection strategies for predicting patient response to drug therapy, such strategies including detecting the presence or absence n a patient o one or inure of PIK3CA gene amplification, a mutation in PIK3CA, and a decrease in PTEN protein expression, and treating a patient positive for the presence of one or more of same by administering to the subject a pan-ErbB tyrosine kinase inhibitor.

Abstract: Composition of synbodies that bind influenza. The synbodies are composed of two peptides joined on a scaffold.

Abstract: Synbodies specific for Norovirus and coupled with a substrate provide Norovirus binding and detection platforms (FIG. 1). A Norovirus capturing platform, comprising one or more synbodies selected from the group consisting of synbodies 6-6, 92-92, 93-93, and 94-94 coupled to a substrate, has been found to found to bind with either GII.4 Minerva or both GII.4 Minerva and GII.4 Sydney# strains of norovirus.

Abstract: The present invention provides polypeptides, compositions thereof, and methods for use of the polypeptides in treating bacterial infection and for use as disinfectants.

Abstract: The present application provides arrays for use in immunosignaturing and quality control of such arrays. Also disclosed are peptide arrays and uses thereof for diagnostics, therapeutics and research.

Abstract: Improved peptide compositions and synbody compositions are disclosed that show improved stability and antibiotic activity. The new antibacterial peptides for S. aureus have particular D-amino acid substitutions in order to increase protease stability while also preserving marked antibiotic activity. Thus, compositions and methods for treating infections related to S. aureus also are disclosed.

Abstract: The present application provides arrays for use in immunosignaturing and quality control of such arrays. Also disclosed are peptide arrays and uses thereof for diagnostics, therapeutics and research.

Abstract: The invention provides methods for identifying cell binding and/or lytic polypeptides that permit production of specific polypeptide therapeutics in a high throughput manner.

Abstract: A releasable anchorage device for securing seats to tracks in vehicle floors has an elongate body with a fixed, non-slidable downward protrusion at its front end, an actuating lever at its rear end, and sets of slidable securing feet movable relative to the protrusion by the lever operating via an actuating mechanism. The mechanism includes an elongate drive rod connecting the lever to a middle set or front set of the feet which have an anti-rattle mechanism to grip the track, such as by longitudinally-inclined upper surfaces thereon. A rear set of feet may also be slidable and can move together with the middle feet. The lever is easily accessible, being at the rear end, but operates to provide an anti-rattle engagement with the track at an intermediate point along the device, spaced from the rear end, where the prevention of rattling is particularly needed.

Abstract: The present invention provides polypeptides, compositions thereof, and methods for use of the polypeptides in treating bacterial infection and for use as disinfectants.

Abstract: Anchorage device for an anchorage system, especially for vehicle seats, using a floor track having a longitudinal channel whose opening has opposed lips with a series of periodic circular cut-outs, the anchorage device has enlarged slidable feet which are insertable into the opening of the track channel at the cut-outs, and when slid along are held captive beneath the lips of the track. A releasable locking mechanism is provided for locking the device longitudinally to the track, so that the feet can be held in the captive position. Preferably, the device has an elongate body, with the locking mechanism operated by a lever at one end. The top surfaces of at least some of the feet are longitudinally inclined relative to the longitudinal direction. When slid to the captive position they come into contact or near contact with the underside of the track lips, reducing or preventing rattle relative to the track.

Abstract: Methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.

Abstract: Disclosed are compositions relating to novopeptides identified by the presence of frameshift mutations in tumor genes previously not identified as being oncogenic. The disclosed peptides can be used in the disclosed methods for the treatment of cancer.

Abstract: A method for use in forming a molded part includes providing a mold having a cavity and a movable pin, injecting a moldable material into the cavity, biasing the movable pin to maintain an end of the movable pin in contact with the moldable material in the cavity during the curing of the moldable material and until the moldable material is cured, and monitoring movement of the biased movable pin during curing of the moldable material in the mold. Also disclosed is a sensor engageable with an end of a movable pin of a mold for monitoring the forming of a moldable part, and systems employing the same.

Abstract: The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents.